All episodes

Anal Cancer Screening: Implementing Guidelines in the Real World

Challenging Cases in Antiretroviral Therapy and Panel Discussion

Gender-Affirming Hormone Initiation and Antiretroviral Therapy Considerations

PrEP Update: Long-Acting Agents and PrEP During Pregnancy

Update on HIV Primary Care: New Data, New Guidelines

Closing Remarks

CROI 2025 Insights To Treat, Per Chance to Cure HIV

Welcome and Introduction

(January 15, 2025) Latest Update on Urgent Virus Outbreaks: Winter 2025

HIV Prevention and STI Prevention -- Lead: Raphael J. Landovitz, MD

Substance Use Disorder and HIV -- Lead: Sandra A. Springer, MD

Comorbidities in the Setting of ART: Focus on Cardiovascular Disease, Statins, and Weight Management -- Leads: Melanie A. Thompson, MD, and Roger J. Bedimo, MD

When and What to Start -- Lead: Huldrych F. Günthard, MD

Closing Remarks -- Co-Chairs: Rejesh T. Gandhi, MD, and Michael S. Saag, MD

Welcome and Introduction -- Co-Chairs: Rejesh T. Gandhi, MD, and Michael S. Saag, MD

Coinfections in the Setting of ART: Tuberculosis, Opportunistic Infections, and Others -- Lead: Brenda E. Crabtree Ramírez, MD

When and How to Switch -- Lead: Rajesh T. Gandhi, MD

Comprehensive Overview: Latest Guidelines for Screening and Treatment for Human Papillomavirus and Anal Cancer -- Presenter: Timothy J. Wilkin, MD, MPH

Closing -- Co-Chairs: Henry Masur, MD and Michael S. Saag, MD

Treating and Preventing HIV: Updates From the IAS–USA Guidelines -- Presenter: Rajesh T. Gandhi, MD

Advancements in Long-Acting Drugs for HIV Treatment and Prevention, Including Emerging Therapies -- Presenter: Roy M. Gulick, MD, MPH

A Pound of Cure: Exploring the Potential Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RAs) and Other Substance Use Treatments Beyond Opioids -- Presenter: Ellen F. Eaton, MD

Strategies to Reduce Cardiovascular Disease in Persons With HIV in 2024 – Where Do We Go From Here? -- Presenter: Priscilla Y. Hsue, MD

Welcome and Introductions -- Co-Chairs: Henry Masur, MD and Michael S. Saag, MD

Key Opportunistic Infections: Not Gone and Not Forgotten – Cases from the Clinic and Panel Discussion -- Presenter: Constance A. Benson, MD

Welcome (Day 2)

HIV and Aging: Focus on Neurocognitive Impairment -- Presenter: Meredith Greene, MD

Substance Use Disorder, HIV, and Mental Health -- Presenter: Karinn A. Glover, MD, MPH

Interactive ART Cases From the Clinic(ians): Case-Based Panel Discussion -- Presenter: Michael S. Saag, MD

Infections and Sexual Health – What’s New in Detection and Treatment: STI Updates From the Treatment Guidelines -- Presenter: Natalie Neu, MD, MPH

Diagnosis, Treatment, and Complications of Diabetes in People With HIV -- Presenter: Todd T. Brown, MD, PhD

Practice Changing Updates in the Primary Care Management of People With HIV -- Presenter: David H. Spach, MD

Comprehensive Review of Weight Loss Management -- Presenter: Zoobia W. Chaudhry, MBBS

From Cases to Care: Exploring Long-Acting HIV Therapies in Practice -- Presenter: Joshua P. Havens, PharmD

Top 10 Questions to the NCCC Warmline: What’s Coming Up for Providers Across the Country? -- Presenter: Carolyn Chu, MD, MSc

HIV Care: Successfully Navigating the Transition from Pediatric to Adult Care -- Presenter: Allison L. Agwu, MD, ScM

Shots, Shots, Shots: Updates on Oral and Injectable Preexposure Prophylaxis -- Presenter: Hyman Scott, MD, MPH

Welcome (Day 3)

New and Investigational Antiretroviral Drugs and Formulations: Transforming the Care of People with HIV -- Presenter: Rajesh T. Gandhi, MD

Patient Engagement in Care: Strategies to Inform Implementation Science and Practice -- Presenter: Michael J. Mugavero, MD, MHSc

‘Weighing’ the Clinical Benefits of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) -- Presenter: Suman Srinivasa, MD, MS

HRSA Ryan White HIV/AIDS Program Updates -- Presenter: Laura W. Cheever, MD, ScM

Treatment and Prevention of Syphilis in People With HIV -- Presenter: Kimberly A. Workowski, MD

Welcome and Introduction (Day 1)

Dermatologic Manifestations of HIV -- Presenter: Toby Maurer, MD

(October 4, 2024) Latest Update on Urgent Virus Outbreaks: October 2024

Cryptococcal Meningitis State Of The Art For Diagnosis, Treatment, And Prevention 1

No Brainers Think Again OIs In Brain, Lungs, And Elsewhere

Opportunistic Infections Past, Present, What's New, & Review Of Guidelines

Pneumocystis What’s Old And What’s New

Treatment And Diagnosis Of Mycobacterium Avium Complex Disease

Welcome And Introductions

Closing Remarks

(June 11) Latest Update on Urgent Virus Outbreaks: June 2024

Welcome and introductions

State of the ART: Hot Antiretroviral Updates from CROI 2024 and Beyond

“Weighing In” on GLP-1 Receptor Agonists for People With HIV

The Latest Updates on Immunizations for People With HIV

Challenging Cases in Antiretroviral Therapy and Panel Discussion

Closing

Statins: Young at Heart

No Mo FOMO—In Case You Missed It: Recent Changes in Guidelines, New Publications and Conferences

The Art and Science of Prevention: Updates in HIV PrEP and Doxy-PEP

Welcome and Introductions

HIV Cure: Where Are We and Do We Have a Map?

Key Updates from CROI 2024

Managing Substance Use Disorders: Opioids, Stimulants, and Alcohol

Antiretroviral Therapy Cases From the Clinic(ians)

Sexually Transmitted Infections: Challenges in Management and Prevention

Reducing Cardiovascular Events in People With HIV: A Much-Needed REPRIEVE For an At-Risk Population

Hit Me With Your Best Shot! Routine Immunizations for People With HIV

Closing Remarks

(March 26, 2024) Latest Update on Urgent Virus Outbreaks: March 2024

Welcome and Introductions

From Data to Options: Advances in Sexually Transmitted Infection Prevention

Managing Substance Use Disorders: Opioids, Stimulants, and Alcohol

Key Updates from CROI 2024

Challenging Cases in Antiretroviral Therapy and Panel Discussion

Statins in the Post–REPRIEVE Era: Who, When, and Why

Hypertension and Cardiometabolic Issues in People With HIV: 2024 Update

“Weighing In” on GLP-1 Receptor Agonists for People With HIV

LA Agents for HIV Therapeutics and Prevention: Where We Are, Where We Aren’t, & Where We’re Going

Resistance in Long-Acting Therapy for Prevention and Treatment: Uncommon Outcome or Achilles Heel

Welcome and Introduction

Sex, Drugs, and ART: Addressing Substance Use in People with HIV

Preventing Heart Disease in People with HIV: Delivering REPRIEVE from a Major Comorbidity

“Weighing In” on GLP-1 Receptor Agonists for People With HIV

Updates in STI Prevention and Treatment: DoxyPEP and More

The Future of ART

Closing

State of the Science: What We Know about Long-Acting Injectable Agents for Treatment of HIV

State of the Science: What We Know about Long-Acting Injectable Agents for HIV Prevention

Annoying But Necessary: Navigating the Challenges of LA Treatment & Prevention Strategies

Welcome and Introduction

Closing Remarks

Challenging Cases in LA Treatment and Prevention: What Would You Do?

(October 19, 2023) Latest Update on Urgent Virus Outbreaks: October 2023

(August 1, 2023) Latest Update On Urgent Virus Outbreaks August 2023

Welcome and Introductions

Patient Perspective: Long COVID